Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 12,615 | 19,809 | 26,163 | 24,294 | 27,935 |
| Operating Income | -12,615 | -19,809 | -26,163 | -24,294 | -27,935 |
| Other Income | 1,840 | 2,004 | 1,941 | 959 | 298 |
| Pre-tax Income | -10,775 | -17,805 | -24,222 | -23,335 | -27,637 |
| Net Income Continuous | -10,775 | -17,805 | -24,222 | -23,335 | -27,637 |
| Net Income | $-10,775 | $-17,805 | $-24,222 | $-23,335 | $-27,637 |
| EPS Basic Total Ops | -0.18 | -0.30 | -0.40 | -0.40 | -0.48 |
| EPS Basic Continuous Ops | -0.18 | -0.30 | -0.41 | -0.40 | -0.48 |
| EPS Diluted Total Ops | -0.18 | -0.30 | -0.40 | -0.40 | -0.48 |
| EPS Diluted Continuous Ops | -0.18 | -0.30 | -0.41 | -0.40 | -0.48 |
| EPS Diluted Before Non-Recurring Items | -0.18 | -0.30 | -0.41 | -0.40 | -0.48 |
| EBITDA(a) | $-13,459 | $-21,231 | $-26,163 | $-24,294 | $-27,935 |